SIRT3‐deficient mice develop cardiac hypertrophy and interstitial fibrosis after various hypertrophy stimulations because SIRT3 deacetylates and activates FOXO3α, which increases the transcription of antioxidant genes, thereby inhibiting the production of reactive oxygen species (ROS) in stimulated cells.9 Here, SIRT3 is linked to cardiac hypertrophy.